Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1272)
|
Core Tip (1280)
|
Full Article (HTML) (4285)
|
Full Article (PDF)-777K (668)
|
Audio-357K (37)
|
Peer-Review Report-122K (202)
|
Answering Reviewers-64K (250)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (12388)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications

World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1518)
|
Core Tip (1533)
|
Full Article (HTML) (13781)
|
Figures (1-4) (1818)
|
Full Article (PDF)-948K (1366)
|
Audio-1310K (33)
|
Peer-Review Report-106K (440)
|
Answering Reviewers-19K (294)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (61)
|
Total Visits (28552)
|
Similar Articles (503)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model

World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1396)
|
Core Tip (1403)
|
Full Article (HTML) (5198)
|
Figures (1-2) (374)
|
Tables (1-2) (364)
|
Full Article (PDF)-1246K (769)
|
Audio-442K (34)
|
Peer-Review Report-131K (369)
|
Answering Reviewers-120K (232)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (19072)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1296)
|
Core Tip (1282)
|
Full Article (HTML) (4123)
|
Figures (1-3) (401)
|
Tables (1-1) (389)
|
Full Article (PDF)-814K (571)
|
Audio-757K (29)
|
Peer-Review Report-105K (285)
|
Answering Reviewers-109K (254)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (17508)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1346)
|
Core Tip (1380)
|
Full Article (HTML) (4007)
|
Tables (1-3) (360)
|
Full Article (PDF)-799K (539)
|
Audio-1969K (21)
|
Peer-Review Report-132K (256)
|
Answering Reviewers-50K (229)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15220)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open